Skip to main content
Article

WCN25-3811 PROGRESSION OF ANTICOAGULANT-RELATED NEPHROPATHY AFTER ANTICOAGULANT THERAPY

Sherzod AbdullaevNephrology, Republican specialized scientific and practical center of nephrology and kidney transplantation, Tashkent, UzbekistanRanokhon IgamberdievaInternal medicine, nephrology, haemodialysis, Tashkent pediatric medical institute, Tashkent, Uzbekistan
ABI

Abstract

Anticoagulant-related nephropathy (ARN) is a recently discovered cause of AKI and possibly, progressive CKD as well. It occurs in patients receiving oral anticoagulant therapy, namely warfarin or a novel oral anticoagulant (NOAC). Many multi-center studies indicate that ARN occurs in up to 30 % of patients exposed to supratherapeutic INR when treated with vitamin K antagonists but little is known about ARN in direct oral anticoagulants. Our aim was to determine the incidence of ARN in patients with atrial fibrillation initiating (AF) oral anticoagulant treatment.

Topics

Identifiers

Citations and references

Cited by 00 references
Metrics — AkademScholar · Coming soon